Mid Continent Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CS
Mid Continent Capital's XBI Position: Q3 2015 in Review
Mid Continent Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2015, closing a stake of 19,995 shares — an estimated $1.68M sold.
Mid Continent Capital first reported a position in XBI in Q1 2015 and held it in 2 quarters. The position peaked at $1.68M in Q2 2015. 196 funds tracked by Wall St. Rank hold XBI as of Q3 2015.
- Mid Continent Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2015 after selling out during the quarter.
- Mid Continent Capital sold 19,995 State Street SPDR S&P Biotech ETF shares in Q3 2015, an estimated $1.68M.
- Mid Continent Capital first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and held it in 2 quarters.
- Mid Continent Capital's State Street SPDR S&P Biotech ETF position peaked at $1.68M in Q2 2015.
- 196 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2015.
Based on Mid Continent Capital's 13F filing for Q3 2015, filed 22 Oct 2015.